Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Biome Australia Ltd ( (AU:BIO) ) has shared an announcement.
Biome Australia Limited has expanded its distribution in the Australian practitioner and pharmacy markets to over 6,000 locations, achieving a 20% growth over six months. This expansion includes new distribution deals with USF Dispensaries in Victoria and Greenleaf Pharmacies in Western Australia, contributing to 33% of the company’s Vision 27 Strategic plan target of 8,000 locations by FY27. The growth is supported by significant sales increases reported by key partners, and the company’s products offer pharmacies new opportunities to enhance profitability.
More about Biome Australia Ltd
Biome Australia Limited operates in the microbiome health sector, providing complementary medicine products. The company is known for its Activated Probiotics® product range, which is a high-growth brand within the Australian market.
YTD Price Performance: -9.32%
Average Trading Volume: 600,766
Technical Sentiment Consensus Rating: Sell
For an in-depth examination of BIO stock, go to TipRanks’ Stock Analysis page.
